These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 38767273)

  • 1. Prevalence of co-existent COVID-19-associated pulmonary aspergillosis (CAPA) and its impact on early mortality in patients with COVID-19-associated pulmonary mucormycosis (CAPM).
    Muthu V; Agarwal R; Rudramurthy SM; Thangaraju D; Shevkani MR; Patel AK; Shastri PS; Tayade A; Bhandari S; Gella V; Savio J; Madan S; Hallur V; Maturu VN; Srinivasan A; Sethuraman N; Sibia RPS; Pujari S; Mehta R; Singhal T; Saxena P; Gupta V; Nagvekar V; Prayag P; Patel D; Xess I; Savaj P; Sehgal IS; Panda N; Rajagopal GD; Parwani RS; Patel K; Deshmukh A; Vyas A; Gandra RR; Sistla SK; Padaki PA; Ramar D; Panigrahi MK; Sarkar S; Rachagulla B; Vallandaramam P; Premachandran KP; Pawar S; Gugale P; Hosamani P; Dutt SN; Nair S; Kalpakkam H; Badhwar S; Kompella KK; Singla N; Navlakhe M; Prayag A; Singh G; Dhakecha P; Chakrabarti A
    Mycoses; 2024 May; 67(5):e13745. PubMed ID: 38767273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors, mortality, and predictors of survival in COVID-19-associated pulmonary mucormycosis: a multicentre retrospective study from India.
    Muthu V; Agarwal R; Rudramurthy SM; Thangaraju D; Shevkani MR; Patel AK; Shastri PS; Tayade A; Bhandari S; Gella V; Savio J; Madan S; Hallur V; Maturu VN; Srinivasan A; Sethuraman N; Singh Sibia RP; Pujari S; Mehta R; Singhal T; Saxena P; Gupta V; Nagvekar V; Prayag P; Patel D; Xess I; Savaj P; Sehgal IS; Panda N; Rajagopal GD; Parwani RS; Patel K; Deshmukh A; Vyas A; Gandra RR; Sistla SK; Padaki PA; Ramar D; Sarkar S; Rachagulla B; Vallandaramam P; Premachandran KP; Pawar S; Gugale P; Hosamani P; Dutt SN; Nair S; Kalpakkam H; Badhwar S; Kompella KK; Singla N; Navlakhe M; Prayag A; Singh G; Dhakecha P; Chakrabarti A
    Clin Microbiol Infect; 2024 Mar; 30(3):368-374. PubMed ID: 38081413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expert consensus on diagnosis and treatment of severe COVID-19 associated pulmonary
    ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Jan; 47(1):10-23. PubMed ID: 38062689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19-Associated Pulmonary Aspergillosis, Fungemia, and Pneumocystosis in the Intensive Care Unit: a Retrospective Multicenter Observational Cohort during the First French Pandemic Wave.
    Bretagne S; Sitbon K; Botterel F; Dellière S; Letscher-Bru V; Chouaki T; Bellanger AP; Bonnal C; Fekkar A; Persat F; Costa D; Bourgeois N; Dalle F; Lussac-Sorton F; Paugam A; Cassaing S; Hasseine L; Huguenin A; Guennouni N; Mazars E; Le Gal S; Sasso M; Brun S; Cadot L; Cassagne C; Cateau E; Gangneux JP; Moniot M; Roux AL; Tournus C; Desbois-Nogard N; Le Coustumier A; Moquet O; Alanio A; Dromer F;
    Microbiol Spectr; 2021 Oct; 9(2):e0113821. PubMed ID: 34668768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary Artery Pseudoaneurysm in COVID-19-Associated Pulmonary Mucormycosis: Case Series and Systematic Review of the Literature.
    Pruthi H; Muthu V; Bhujade H; Sharma A; Baloji A; Ratnakara RG; Bal A; Singh H; Sandhu MS; Negi S; Chakrabarti A; Singhal M
    Mycopathologia; 2022 Feb; 187(1):31-37. PubMed ID: 34936060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of cases with co-infection of COVID-19 and pulmonary aspergillosis.
    Zheng Hu H; Wu LB; Liu Q; Wu BY; Wang Y; Wang RY
    New Microbiol; 2024 May; 47(1):98-102. PubMed ID: 38700889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19-associated pulmonary aspergillosis (CAPA) in Iranian patients admitted with severe COVID-19 pneumonia.
    Erami M; Hashemi SJ; Raiesi O; Fattahi M; Getso MI; Momen-Heravi M; Daie Ghazvini R; Khodavaisy S; Parviz S; Mehri N; Babaei M
    Infection; 2023 Feb; 51(1):223-230. PubMed ID: 36107379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune and metabolic perturbations in COVID-19-associated pulmonary mucormycosis: A transcriptome analysis of innate immune cells.
    Dhaliwal M; Muthu V; Sharma A; Raj K; Rudramurthy SM; Agarwal R; Kaur H; Rawat A; Singh S; Chakrabarti A
    Mycoses; 2024 Jan; 67(1):e13679. PubMed ID: 38214399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-COVID pulmonary fungal infections: An unanticipated predicament or a ticking time bomb? Clinico-microbiological profile of cases encountered during the second wave of COVID-19 pandemic at a teaching hospital in the Himalayas with a brief literature review.
    Puri O; Bhatia M; Rekha US; Chakraborty D; Dua R; Dhar M; Chauhan U; Prasad A; Kalita D; Kaistha N
    J Family Med Prim Care; 2023 Dec; 12(12):3228-3235. PubMed ID: 38361892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19-associated mixed mold infection: A case report of aspergillosis and mucormycosis and a literature review.
    Benhadid-Brahmi Y; Hamane S; Soyer B; Mebazaa A; Alanio A; Chousterman B; Bretagne S; Dellière S
    J Mycol Med; 2022 Mar; 32(1):101231. PubMed ID: 34864498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19-associated pulmonary aspergillosis: a prospective single-center dual case series.
    Meijer EFJ; Dofferhoff ASM; Hoiting O; Meis JF
    Mycoses; 2021 Apr; 64(4):457-464. PubMed ID: 33569857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19-associated pulmonary aspergillosis (CAPA) in hematological patients: Could antifungal prophylaxis be necessary? A nationwide study.
    Tamayo-Velasco Á; López-Herrero R; Gómez-García LM; Sánchez-de Prada L; Aguilar-Monserrate G; Martín-Fernández M; Bardají-Carrillo M; Álvaro-Meca A; Tamayo E; Resino S; Miramontes-González JP; Peñarrubia-Ponce MJ
    J Infect Public Health; 2024 Jun; 17(6):939-946. PubMed ID: 38613930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic and Phenotypic Analysis of COVID-19-Associated Pulmonary Aspergillosis Isolates of Aspergillus fumigatus.
    Steenwyk JL; Mead ME; de Castro PA; Valero C; Damasio A; Dos Santos RAC; Labella AL; Li Y; Knowles SL; Raja HA; Oberlies NH; Zhou X; Cornely OA; Fuchs F; Koehler P; Goldman GH; Rokas A
    Microbiol Spectr; 2021 Sep; 9(1):e0001021. PubMed ID: 34106569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study.
    Gangneux JP; Dannaoui E; Fekkar A; Luyt CE; Botterel F; De Prost N; Tadié JM; Reizine F; Houzé S; Timsit JF; Iriart X; Riu-Poulenc B; Sendid B; Nseir S; Persat F; Wallet F; Le Pape P; Canet E; Novara A; Manai M; Cateau E; Thille AW; Brun S; Cohen Y; Alanio A; Mégarbane B; Cornet M; Terzi N; Lamhaut L; Sabourin E; Desoubeaux G; Ehrmann S; Hennequin C; Voiriot G; Nevez G; Aubron C; Letscher-Bru V; Meziani F; Blaize M; Mayaux J; Monsel A; Boquel F; Robert-Gangneux F; Le Tulzo Y; Seguin P; Guegan H; Autier B; Lesouhaitier M; Pelletier R; Belaz S; Bonnal C; Berry A; Leroy J; François N; Richard JC; Paulus S; Argaud L; Dupont D; Menotti J; Morio F; Soulié M; Schwebel C; Garnaud C; Guitard J; Le Gal S; Quinio D; Morcet J; Laviolle B; Zahar JR; Bougnoux ME
    Lancet Respir Med; 2022 Feb; 10(2):180-190. PubMed ID: 34843666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicentre observational study on the epidemiology, risk factors, management and outcomes of mucormycosis in India.
    Patel A; Kaur H; Xess I; Michael JS; Savio J; Rudramurthy S; Singh R; Shastri P; Umabala P; Sardana R; Kindo A; Capoor MR; Mohan S; Muthu V; Agarwal R; Chakrabarti A
    Clin Microbiol Infect; 2020 Jul; 26(7):944.e9-944.e15. PubMed ID: 31811914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung epithelial and myeloid innate immunity in influenza-associated or COVID-19-associated pulmonary aspergillosis: an observational study.
    Feys S; Gonçalves SM; Khan M; Choi S; Boeckx B; Chatelain D; Cunha C; Debaveye Y; Hermans G; Hertoghs M; Humblet-Baron S; Jacobs C; Lagrou K; Marcelis L; Maizel J; Meersseman P; Nyga R; Seldeslachts L; Starick MR; Thevissen K; Vandenbriele C; Vanderbeke L; Vande Velde G; Van Regenmortel N; Vanstapel A; Vanmassenhove S; Wilmer A; Van De Veerdonk FL; De Hertogh G; Mombaerts P; Lambrechts D; Carvalho A; Van Weyenbergh J; Wauters J
    Lancet Respir Med; 2022 Dec; 10(12):1147-1159. PubMed ID: 36029799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defining COVID-19-associated pulmonary aspergillosis: systematic review and meta-analysis.
    Kariyawasam RM; Dingle TC; Kula BE; Vandermeer B; Sligl WI; Schwartz IS
    Clin Microbiol Infect; 2022 Jul; 28(7):920-927. PubMed ID: 35150878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 associated mold infections: Review of COVID-19 associated pulmonary aspergillosis and mucormycosis.
    Huang SF; Ying-Jung Wu A; Shin-Jung Lee S; Huang YS; Lee CY; Yang TL; Wang HW; Chen HJ; Chen YC; Ho TS; Kuo CF; Lin YT;
    J Microbiol Immunol Infect; 2023 Jun; 56(3):442-454. PubMed ID: 36586744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invasive Mucormycosis and Aspergillosis Coinfection Associated with Post-COVID-19 Pneumonia in a Tertiary Care Hospital.
    Paul M; Sasidharan J; Taneja J; Chatterjee K; Abbas SZ; Chowdhury V; Das A
    Med Mycol J; 2022; 63(3):59-64. PubMed ID: 36047183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of influenza- and COVID-19-associated pulmonary aspergillosis in China.
    Zhao J; Zhuo X; Pu D; Fan G; Lu B; Cao B
    Eur J Clin Microbiol Infect Dis; 2024 Apr; 43(4):683-692. PubMed ID: 38326545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.